Clinical Need
Addressing Unmet Challenges
____
Bilitech’s Regenerative Medicine Solutions break new ground into a previously unexploited £8bn market
350,000 new cases per annum with bile duct diseases
75,000 new cases per annum with disease affecting large ducts amenable to surgical replacement
275,000 new cases per annum with diffuse disease affecting small ducts not amenable to surgery
Minimal treatment options other than surgery or a liver transplantation
Accounting for 30% of adult and 70% of paediatric liver transplantation